📊DOL Seeks Comments on Worker Profiling and Reemployment Services
The Department of Labor's (DOL) Employment and Training Administration (ETA) is soliciting comments concerning a proposed extension for the authority to conduct the information collection request (ICR) titled, "Worker Profiling and Reemployment Services Activity and Worker Profiling and Reemployment Services Outcomes." This comment request is part of continuing Departmental efforts to reduce paperwork and respondent burden in accordance with the Paperwork Reduction Act of 1995 (PRA).
Learn More💊FDA Issues Guidance on Prioritized Generic Drug Submissions
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "ANDAs: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions." This guidance describes the facility information to be submitted in a pre-submission facility correspondence (PFC) and how FDA will use this information to set a review goal for a priority abbreviated new drug application (ANDA). This guidance incorporates a program enhancement agreed upon by the Agency and industry as part of the negotiations relating to reauthorization of the Generic Drug User Fee Amendments (GDUFA) and as described in "GDUFA Reauthorization Performance Goals and Program Enhancements Fiscal Years 2023-2027" (GDUFA III commitment letter). This guidance finalizes for implementation the draft guidance of the same title issued on December 5, 2022.
Learn More🧪FDA Announces Public Meeting on Unapproved Fluoride Prescription Drugs
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population." The purpose of the hybrid public meeting is to seek public input on the clinical use and safety concerns associated with the use of orally ingestible unapproved prescription drug products containing fluoride in the pediatric population. The public meeting will be facilitated by the Reagan-Udall Foundation for the FDA. FDA is establishing a docket for public comment on this topic.
Learn More💊FDA's Patent Extension Review for ROLVEDON and Its Business Impact
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for ROLVEDON and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Learn More🐟Public Meetings on Fishery Management in American Samoa
The Western Pacific Fishery Management Council (Council) will hold a meeting of its American Samoa Council Advisors and its American Samoa Regional Ecosystem Advisory Committee (REAC) meeting to discuss and make recommendations on fishery management issues in the western Pacific region.
Learn More🏠30-Day Notice on Operating Fund Shortfall Program Financial Reporting
HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comments from all interested parties on the proposed collection of information. The purpose of this notice is to allow for 30 days of public comment.
Learn More📊CDC Invites Comments on Health Message Data Collection
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled NCEZID Rapid Message Testing & Development System. This program will enable the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) to test health messages and gather information to inform the development of health messages.
Learn More💖Million Hearts® Hypertension Control Challenge and Business Impact
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled the Million Hearts[supreg] Hypertension Control Challenge. This program is a national initiative to prevent one million heart attacks and strokes by 2027.
Learn More🪶Repatriation Notice from California Department of Parks and Recreation
In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the California Department of Parks and Recreation intends to repatriate certain cultural items that meet the definition of objects of cultural patrimony and that have a cultural affiliation with the Indian Tribes or Native Hawaiian organizations in this notice.
Learn More🚂Regulatory Notice on Waybill Data Use Requests by ACC
The Surface Transportation Board has received a request for access to specific Carload Waybill Sample data by Thompson Hine and Escalation Consultants on behalf of the American Chemistry Council (ACC). Due to the confidential nature of waybill data, objections can be filed within 14 days, highlighting the importance of confidentiality in business operations and data usage regulations.
Learn More